Alume Biosciences Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.16M
- Investors
-
9
Alume Biosciences General Information
Description
Developer of a nerve illumination technology designed to help doctors perform precision surgery. The company's technology illuminates nerves during surgery, making them visible to the surgical team, enabling surgeons to prevent nerve damage while performing complex organ surgeries.
Contact Information
Website
www.alumebiosciences.comCorporate Office
- 2223 Avenida de La Playa
- Suite 205
- La Jolla, CA 92037
- United States
Corporate Office
- 2223 Avenida de La Playa
- Suite 205
- La Jolla, CA 92037
- United States
Alume Biosciences Timeline
Alume Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 01-May-2026 | $2.16M | Completed | Clinical Trials - Phase 3 | ||
| 10. Later Stage VC (Series C) | 18-Feb-2026 | Completed | Clinical Trials - Phase 3 | |||
| 9. Grant | 08-Sep-2023 | Completed | Clinical Trials - Phase 3 | |||
| 8. Later Stage VC (Series B) | 06-Jan-2023 | Completed | Clinical Trials - Phase 3 | |||
| 7. Grant | 09-Sep-2022 | Completed | Pre-Clinical Trials | |||
| 6. Grant | 30-Sep-2020 | Completed | Pre-Clinical Trials | |||
| 5. Early Stage VC (Series A2) | 26-Aug-2020 | Completed | Pre-Clinical Trials | |||
| 4. Early Stage VC (Series A) | 11-Jul-2019 | Completed | Startup | |||
| 3. Grant | 15-Apr-2019 | $1.18M | Completed | Startup | ||
| 2. Accelerator/Incubator | 15-Sep-2018 | Completed | Startup |
Alume Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A2 | ||||||||
| Series A1 | 400,000 | $0.000010 | $0.32 | $4.02 | $4.02 | 1x | $4.02 | 2.1% |
| Series A | 2,000,000 | $0.000010 | $0.32 | $4.02 | $4.02 | 1x | $4.02 | 10.48% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Alume Biosciences Patents
Alume Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4709405-A2 | Fluorescein-labeled nerve targeting peptide formulations and related methods | Pending | 11-May-2023 | ||
| US-20260306676-A1 | Fluorescein-labeled nerve targeting peptide formulations and related methods | Pending | 11-May-2023 | ||
| WO-2024233683-A2 | Fluorescein-labeled nerve targeting peptide formulations and related methods | Inactive | 11-May-2023 | ||
| WO-2024233683-A3 | Fluorescein-labeled nerve targeting peptide formulations and related methods | Inactive | 11-May-2023 | ||
| JP-2026516124-A | Fluorescein-labeled neuronal targeting peptide formulation and related methods | Pending | 11-May-2023 | A61K49/0041 |
Alume Biosciences Signals
Alume Biosciences Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| U.S. Department of Health and Human Services | Government | |||
| Small Business Innovation Research and Small Business Technology Transfer Programs | Government | |||
| National Institutes of Neurological Disorders and Stroke | Government | |||
| ALMA Life Sciences | Venture Capital | Minority | ||
| Biobrit | Venture Capital | Minority |
Alume Biosciences FAQs
-
When was Alume Biosciences founded?
Alume Biosciences was founded in 2017.
-
Where is Alume Biosciences headquartered?
Alume Biosciences is headquartered in La Jolla, CA.
-
What is the size of Alume Biosciences?
Alume Biosciences has 11 total employees.
-
What industry is Alume Biosciences in?
Alume Biosciences’s primary industry is Biotechnology.
-
Is Alume Biosciences a private or public company?
Alume Biosciences is a Private company.
-
What is Alume Biosciences’s current revenue?
The current revenue for Alume Biosciences is .
-
How much funding has Alume Biosciences raised over time?
Alume Biosciences has raised $33.3M.
-
Who are Alume Biosciences’s investors?
U.S. Department of Health and Human Services, Small Business Innovation Research and Small Business Technology Transfer Programs, National Institutes of Neurological Disorders and Stroke, ALMA Life Sciences, and Biobrit are 5 of 9 investors who have invested in Alume Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process